Pharmaceutical development is the process of identifying and assessing the procedures required to turn an active pharmaceutical component into a drug product that is appropriate for the use for which it is intended. This will be for small-scale production of a product to be utilised in clinical trials in the early phases of medication development. In order to be appropriate for production on a commercial scale, the method will have to be modified and enhanced if the tests are successful. Measuring the characteristics of the drug material and determining the essential qualities of the desired medication product are the first steps in the pharmaceutical development process. This procedure will involve determining the drug's stability and absorption characteristics as well as the best route of delivery (oral, parenteral or for local administration). It is crucial to match the qualities of the drug material with the formulation required to achieve the clinical and commercial profile. Drug substance characteristics may significantly restrict the types of formulations that may be employed and necessitate in-depth research to fulfil the necessary profile. In order to create a successful commercial product, pharmaceutical development of the drug substance, the drug product, and its manufacturing behaviour are required if the drug application is successful. The finished product needs to be secure, dependable, and efficient.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation